Demonstrating the full societal value of adult immunization: The importance of adopting a prevention-first mindset

30 May 2024 Geneva, CH
Date

30 May 2024

Time

18:00 - 20:00 CET

Hosts

IFPMA

Location

Hotel Intercontinental 7-9, Chemin du Petit-Saconnex, 1209 Geneva

The Office of Health Economics, commissioned by IFPMA, recently published a report on the Socio-economic Value of Adult Immunization, bringing new evidence to support the important role of adult vaccination programs in addressing key health and societal challenges while aligning with global agendas such as the UN Sustainable Development Goals and the WHO Immunisation Agenda 2030 (IA2030). This panel discussion will explore the value of adult immunization not only for healthcare systems and population health, but also its cost-effectiveness, impact on productivity, and associated economic benefits.

For more information, please contact events@ifpma.org.

 

This hybrid event, hosted by IFPMA, will bring together senior representatives from governments, multilateral organizations, and the private sector.

For in-person participation register here.

For virtual participation register here.

For more information, please contact events@ifpma.org.

Address

7-9, Chemin du Petit-Saconnex, 1209 Geneva

Speakers

Lise Pedersen Moderator; Journalist

Lise Pedersen is a journalist and bilingual conference moderator (English-French) with over two decades of experience in the media industry. Her career includes an extensive tenure as a news reporter, producer, and presenter at Euronews, Europe’s leading international news channel. In 2018, Lise transitioned to specialize on moderating for a diverse range of high-profile public and private events. Alongside these engagements, Lise is a regular contributor to Variety magazine, covering film industry news and festivals across Europe.

Lise holds a Post-Graduate Diploma in Broadcast Journalism from Falmouth College of Arts, a B.A. in International Relations and German from the University of Sussex, and a French Baccalaureate.

Lotte Steuten Deputy Chief Executive, Office of Health Economics

Prof. Lotte Steuten, PhD, is Deputy Chief Executive of the not-for-profit Office of Health Economics (OHE) and the scientific and business lead for its international research-led work program. Alongside her position at OHE, Lotte is a Visiting Honorary Professor at City University of London, an associate editor for Value in Health and served as a member of the ISPOR Board of Directors. She has published >100 peer–reviewed papers.

Lotte specializes in quantitative methods for estimating the expected health and economic benefits of healthcare interventions across their lifecycle. She has applied this to various technologies and disease areas notably vaccines, antibiotics, oncology, rare diseases, ATMPs and diagnostics.

Before joining OHE, Lotte worked in Seattle (US) as an Associate Professor at the University of Washington and at the Fred Hutch Cancer Research Center. She graduated cum laude with her PhD from Maastricht University (NL).

Christi Kelsey Head Global Vaccines Commercial

Christi Kelsey is the SVP of Global Product Strategy for GSKs vaccine business accountable for global strategic and operational plan for GSK’s >£7B portfolio comprised of over 15 vaccines. In this role, she has worked to refocus GSK’s strategy with the aim to return the company to market leadership position and was instrumental in working cross functionally to achieve approval of the world’s first RSV vaccines for older adults. Under her leadership, Shingrix, GSKs flagship brand, has exceeded expectations supported by strong geo-expansion and life cycle management plans.

Christi brings over 25 years of broad industry experience with key roles across the Research & Development and Commercial spectrum in both biotech and pharmaceutical organizations across the US, Europe and Asia Pacific. She joined GSK in 2006 and has held leadership positions at local, global and regional levels working for Bristol-Myers Squibb, Johnson and Johnson and Cytogen, an oncology Biotech. She has established herself as a launch specialist and collaborative leader with unique experience in specialty products.

Christi joined the vaccines business from her role as Vice President and General Manager, Australia where she was recognized for returning the business to growth and building a strong, resilient culture. Prior to this, Christi was the Global Lead for GSK’s Biologics Portfolio responsible for managing a diverse global business in a key growth area for the organisation which she joined after successfully launching the NUCALA Biologics business in the US. Her early GSK career included key US based leadership roles in brand marketing where she led the breast cancer portfolio as well as sales leadership roles in the IDN space.

These experiences coupled with a background and personal passion for science have enabled Christi to be a relentless advocate for innovation and patient access. Christi holds a degree in Chemistry from The Ohio State University. She lives with her family in Belgium.

Stefania Maggi Scientific Director, Research Consortium Luigi Amaducci, in the Padua University Hospital

Stefania Maggi, MD, MPH, PhD Research Director, Geriatrician and Epidemiologist, with significant experience in coordinating EU and National-funded epidemiological studies. Her research focuses on the epidemiology of aging and on the analysis of the major determinants of healthy aging through the life-course, with specific interest in nutrition and Immunization.

She is a Board-Certified Geriatrician (University of Padua, Italy) and also obtained a Master in Public Health in Epidemiology and completed a two-year Post-Doctoral Training in Epidemiology, both at the Johns Hopkins University, in Baltimore, MD, USA. Dr. Maggi was the Coordinator of the Program for Research on Aging of WHO, from 1990 to 1993, based at NIA, NIH, Bethesda, MD, USA.

She is currently working as Research Director at the CNR Aging Branch-Institute of Neuroscience in Padua and coordinating the national project on “Multicomponent interventions to improve functional and cognitive wellbeing in older adults in long term care facilities” in the frame program on Aging-The National Recovery and Resilience Plan. Dr. Maggi is the author of about 500 publications in international journals of Medicine and Public Health and is Emeritus Editor in Chief of Aging Clinical and Experimental Research (Springer).

Dr. Jane Barratt Global Advisor at the International Federation on Ageing (IFA)

Dr. Jane M Barratt, Ph.D. is an independent consultant and Global Advisor at the International Federation on Ageing (IFA) an international non-government organisation with general consultative status with the United Nations and its agencies including formal relations with the World Health Organisation (WHO).

Population ageing and disability across the life course have been Jane’s passion and interest across an adventurous career that traverses public and private sectors and many disciplines.

Early in the career she honed her technical and orating skills through an academic career in population ageing and disability at Universities in the United Kingdom and Australia with attention to improved understanding of population-based planning models and service provision.  Thereafter she developed a successful business in strategic planning and relationships alongside senior director and management positions in various international and national not-for-profit organisations.

Jane is a Winston Churchill Fellow and recipient of the Queen Elizabeth II Diamond Jubilee Medal in Canada in recognition of her commitment and passion to enhance the understanding of issues relating to ageing and engaging in dialogue with governments and the private sector to improve the quality of life of older people.

Among her many current positions Jane is a Member of Vision Academy, Co-chair Leadership Coalition DR Barometer Program, Member, Board Baycrest Geriatric Care, Vice Chair, Baycrest Academy for Research and Education, Associate Scientist, Sinai Health System, and Member, WFPHA, Adult Immunisation Task Force. Member of the WHO IA2030, Equitable Immunization as a part of PHC across the Life course (EPL) WG.  Formerly she is a member of the World Economic Forum’s Global Agenda Council on Ageing and Chair, Standing Selection Committee Chair for the Networks of Centres of Excellence of Canada.

 

Top